Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0022116 (ischemia)
 91,303 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The aim of this study was to validate the usefulness of dobutamine stress echocardiography to detect residual ischemia and significant stenosis at the infarct zone in patients with acute myocardial infarction. Dobutamine stress echocardiography and stress thallium-201 single-photon emission computed tomography were performed on 40 consecutive patients 1 month after the onset of acute myocardial infarction. Dobutamine was infused incrementally, and wall motion score index at the infarct zone was calculated before and at peak dobutamine infusion. The patients were divided into three groups according to the change in wall motion at the infarct zone (improved, unchanged, or worsened wall motion, respectively). Tomographic thallium images of the infarct zone were assessed visually. All patients underwent quantitative coronary angiography, and significant stenosis was defined as 50% or greater stenosis. In patients who showed a persistent defect and significant stenosis of the infarct-related artery, resting thallium-201 single-photon emission computed tomography was performed when possible. There was a significantly higher incidence of residual ischemia at the infarct zone in patients with worsened wall motion (85%) and unchanged wall motion (63%) than in those with improved wall motion (8%). The residual stenosis of the infarct-related artery was more severe in patients with worsened or unchanged wall motion than in those with improved wall motion (worsened 82.6% +/- 17.7%, unchanged 93.7% +/- 12.6%, and improved 37.1% +/- 24.4%). The use of worsened or unchanged wall motion at the infarct zone for detecting significant residual stenosis of the infarct-related artery resulted in a sensitivity of 93% and a specificity of 91%, respectively. Worsened wall motion at the infarct zone by dobutamine stress echocardiography strongly suggests residual ischemia. Conversely, less ischemia and less significant stenosis are associated with improved wall motion. Unchanged wall motion suggests severe residual stenosis and sometimes indicates ischemia. It may reflect a hibernating myocardium, but the prognostic significance of this finding should be determined by revascularization.
 ...
PMID:The detection of residual ischemia and stenosis in patients with acute myocardial infarction with dobutamine stress echocardiography. 806 Jun 40

The meaning of a stress-induced ST-segment elevation (delta ST) after acute myocardial infarction is still controversial. Some studies show it is related to asynergy, and other studies show it is related to ischemia. However, no study has compared the delta ST with both stress-induced ischemia and stress-induced asynergy in the same group of patients. With this purpose, 88 patients were studied 16 +/- 4 days after acute myocardial infarction. They were submitted to a dobutamine stress test on two different occasions 1 to 2 days apart. Dobutamine was infused up to 40 micrograms/kg/min with blood pressure and electrocardiographic controls. Thallium-201 single-photon emission computed tomography was performed during the highest dobutamine dose and 3 to 4 hours later. Equilibrium radionuclide ventriculography was performed at rest and during the highest dobutamine dose. Global and regional (hypokinetic area) ejection fractions were quantified. The ST segment was elevated > or = 1 mm in 33 patients at rest and in 71 during stress. A stress-induced delta ST was seen in 66 patients. Redistribution was detected in 65 patients. Multiple regression analysis showed a significant correlation between ST elevation and thallium defect score both at rest and during stress. No correlation was found between delta ST and redistribution score. However, a significant inverse linear correlation was found between the delta ST and the change in regional ejection fraction: the greater the delta ST, the smaller the change in regional ejection fraction with dobutamine. In conclusion, a stress-induced delta ST is not related to ischemia but to stress-induced left ventricular asynergy.
 ...
PMID:Radionuclide studies in patients with stress-induced ST-segment elevation after acute myocardial infarction. 807 5

The use of pharmacologic stress testing for detecting and assessing ischemic heart disease (IHD) is reviewed. Methods of diagnosing IHD are designed to emulate conditions that increase myocardial oxygen demand in order to identify areas of ischemia and atherosclerotic lesions and to evaluate their functional or anatomical importance. Diagnostic methods can be divided into functional assessment with stress testing and anatomical assessment with coronary angiography. Physical stressors, such as exercise or atrial pacing, or pharmacologic stressors, such as vasodilators or beta-adrenergic-receptor agonists, can be used in stress testing. Electrocardiography, thallium planar scintigraphy, echocardiography, and other techniques are used to evaluate the response to stress testing. Unlike exercise stress testing, pharmacologic testing does not require physical exertion. Adenosine, dipyridamole, and dobutamine are the principal agents used in pharmacologic stress testing. Adenosine and dipyridamole mediate coronary artery vasodilation. Adenosine, a direct agonist, has a rapid onset and short duration of action. Dipyridamole, the only agent with approved labeling for use in stress testing, inhibits adenosine indirectly. Dobutamine increases cardiac output and heart rate as well as promoting coronary artery vasodilation. Clinical trials show that all three drugs can be used safely and effectively in patients after acute myocardial infarction or before vascular surgery and in individuals with risk factors for or symptoms of IHD. The sensitivity and specificity of pharmacologic stress testing for detecting IHD are at least as high as those of exercise testing. Minor adverse effects, including chest pain, headache, and facial flushing, are common, but major adverse effects are rare. Pharmacologic stress testing can be used in patients who cannot undergo exercise testing and offers a noninvasive alternative to coronary angiography.
 ...
PMID:Pharmacologic stress testing: experience with dipyridamole, adenosine, and dobutamine. 816 Jun 85

Catecholamines can overcome myocardial stunning. However, a previous report on energy metabolism in stunned myocardium during catecholamine infusion was based on the conventional biochemical methods which might affect contractile function. Twenty farm pigs were anesthetized and underwent 15 min coronary artery occlusion and 2 h reperfusion. Ten pigs were given 10 micrograms/kg/min dobutamine from immediately after and throughout the reperfusion (dobutamine group). The other ten pigs were given saline (control group). Phosphorus-31 magnetic resonance spectroscopy and sonomicrometry were done alternately. Dobutamine improved percent segment shortening after reperfusion (control/dobutamine = 3.8%-5.7%/11.7%-13.4%; P < 0.01). At 15 min ischemia, adenosine triphosphate (ATP) decreased (control/dobutamine = 72 +/- 8%/73 +/- 10%, n.s.), and remained depressed after reperfusion in both groups. After reperfusion, phosphocreatine (PCr) returned to and maintained the preischemic value in the dobutamine group, while in the control group, PCr overshoot (112 +/- 5%) was observed. Except for the presence and absence of PCr overshoot, there was no significant difference of ATP and PCr between the two groups, although rate pressure product was significantly higher in the dobutamine group than in the control group. Regional myocardial blood flow after reperfusion was significantly higher in the dobutamine group. Dobutamine may improve "stunning" through effective improvement of energy utilization and production, indicated by the disappearance of PCr overshoot and maintained ATP level.
 ...
PMID:Dobutamine prevents both myocardial stunning and phosphocreatine overshoot without affecting ATP level. 823 Feb 47

Dobutamine stress echocardiography and stress thallium-201 single-photon emission computed tomography (SPECT) were compared for detecting coronary artery disease in 120 consecutive patients who underwent concomitant quantitative coronary angiography. The left ventricle was divided into anterior, inferior, and lateral regions. Wall motion or perfusion abnormalities observed within each region were classified as ischemia or fixed abnormality. Both tests showed 81% agreement in all 120 patients. Complete agreement was observed in 77% of the 360 regions analyzed. The overall sensitivity of dobutamine stress echocardiography and thallium-201 SPECT for the detection of coronary artery disease was 85% and 89%, and the specificity was 93% and 85%, respectively. A good correlation was found between the wall motion score index and perfusion defect size at peak stress and at rest (r = 0.70). Dobutamine stress echocardiography and thallium-201 SPECT exhibit a comparable accuracy for diagnosing coronary artery disease, localizing coronary artery stenosis, and detecting regional myocardial abnormalities. The wall motion score index may be useful for evaluating the myocardial area at risk.
 ...
PMID:Comparison of dobutamine stress echocardiography and stress thallium-201 single-photon emission computed tomography for detecting coronary artery disease. 831 66

Few studies have examined how load affects the contraction of the myocardium following ischemia. We have therefore developed a canine model in which preload (left atrial pressure) and afterload (mean arterial pressure) are independently varied and heart rate is kept constant. Systolic contraction was found to increase in proportion to preload under preischemic conditions. However, postischemic systolic contractions were reduced and the response to preload was also markedly diminished. Response of systolic thickening to preload was significant in controls (p = 0.003, N = 8) but nonsignificant after 10 minutes of ischemia and 1 hour of reperfusion. Effects of inotropic stimulation were also examined. Dobutamine restored systolic thickening and myocardial contraction to baseline levels following ischemia. However, contraction following dobutamine treatment remained lower than that observed under preischemic conditions. The ideal treatment of the postischemic myocardium should provide low afterload, high heart rate, and high contractility.
 ...
PMID:Regional load dependence of postischemic myocardium. 838 2

Many patients undergoing investigation for coronary artery disease are unable to exercise adequately due to physical or psychological reasons. Thallium-201 imaging using dipyridamole or adenosine may then be a suitable method of assessing myocardial perfusion. In patients with asthma, these drugs are contraindicated because of the risk of provoking bronchospasm. This study assesses the safety of dobutamine for thallium-201 myocardial perfusion imaging in patients with asthma who were unable to perform adequate exercise. Dobutamine was infused at rates < or = 40 micrograms/kg/min in 30 asthmatic patients for thallium-201 emission tomography. The severity of the airway reactivity ranged from mild to severe (bronchodilator treatment ranging from inhaled beta 2 agonists alone to maximal therapy including oral steroids). Coronary angiography was performed in 20 patients. Minor side effects of dobutamine were frequent, but did not limit the infusion rate. There were no episodes of bronchospasm, but tolerable dyspnea occurred in 8 patients who had reversible ischemia; this rapidly resolved with termination of the infusion. There were no serious cardiac complications, but chest pain occurred in 67% of patients. Thallium-201 images were abnormal in 10 of 11 patients with coronary artery disease (sensitivity 91%) and normal in 7 of 9 with normal coronary arteries (specificity 79%). Dobutamine thallium-201 myocardial perfusion tomography is a safe procedure in patients with asthma.
 ...
PMID:Safety of dobutamine stress for thallium-201 myocardial perfusion tomography in patients with asthma. 849 79

The effects on the postischemic myocardium of amrinone and dobutamine were studied in canine hearts that underwent 90 minutes of hypothermic (10 degrees C) arrested ischemia. In an isolated heart preparation cross-circulated by a support dog, left ventricular pressure-volume loops were collected under a constant afterload based on a mock circulatory system and a range of preload conditions controlled by a computerized servo volume pump. Dobutamine (0, 5, 10, 15 micrograms/kg per minute) and amrinone (0, 0.75, 1.5, 3.0 mg/kg) were tested in this order based on the weights of the support dogs in eight experiments. Changes in intrinsic myocardial contractility were analyzed as percent increases in the preload recruitable stroke work area from baselines. Dobutamine exhibited significant dose-related increases in the preload recruitable stroke work area. Amrinone did not produce significant increases in preload recruitable stroke work area at 0.75 mg/kg; amrinone's inotropic effect was equivalent to dobutamine, 5 micrograms/kg per minute at 1.5 mg/kg, and at the maximum dose (3.0 mg/kg) it was equivalent to dobutamine, 10 micrograms/kg per minute. The myocardial energetic efficiency was determined from the analysis of the myocardial oxygen consumption-pressure volume area relationship. The y intercept represents the basal metabolic oxygen requirement of the unloaded beating heart, and the slope is inversely proportional to the rate of energy conversion for increasing loading conditions. Dobutamine significantly increased the y intercepts, but it had no effects on the slopes. These changes demonstrate reduced myocardial efficiencies that are consistent with previous reports. Amrinone (0.75 and 1.50 mg/kg) did not result in change of the y intercepts and the slopes of myocardial oxygen consumption-pressure-volume area relationship from baseline conditions. The y intercept was increased with amrinone (3.0 mg/kg), although still not significantly higher than baseline and not to the extents of the dobutamine group. Dobutamine did not have any primary effect on coronary resistance, while amrinone significantly reduced coronary resistance in all loading conditions at 1.5 and 3.0 mg/kg. This study demonstrates that the inotropic effects of amrinone tested under this constant afterload preparation were lower than those of dobutamine. Amrinone has a superior profile of myocardial efficiency on the postischemic myocardium since it does not produce the oxygen-wasting effects of the traditional inotropic agents such as the beta agonists. This benefit, together with amrinone's coronary dilating effects, critically improves the supply/demand ratio that may be of importance in certain clinical situations.
 ...
PMID:The effects of amrinone versus dobutamine on myocardial mechanics and energetics after hypothermic global ischemia. 850 30

Dobutamine stress echocardiography was used in the diagnosis of myocardial ischemia in patients with implanted VVI pacemakers. A 69-year-old woman received a pacemaker for Mobitz II type AV block in October 1992. She had suffered from chest pain during effort since January 1993 and underwent dobutamine stress echocardiography in April 1993. Although the electrocardiogram failed to identify ischemia because of the pacemaker rhythm, ischemia of the anterior wall was revealed as a worsening of the wall motion on the echocardiogram. The coronary angiogram showed 99% stenosis of the left descending artery. A direct coronary atherectomy was performed on the lesion. A 68-year-old man received a pacemaker for sick sinus syndrome in August 1993. He had suffered from chest oppression during effort since May 1992 and underwent dobutamine stress echocardiography in October 1993. Spontaneous rhythm appeared with dobutamine infusion, but the electrocardiogram could not demonstrate ischemia because of incomparability with the rhythm at rest. Echocardiography detected a new wall motion abnormality of the inferior wall caused by dobutamine. The coronary angiogram showed 90% stenosis of the right coronary artery. PTCA was performed on the lesion. Dobutamine stress echocardiography is useful for the diagnosis of myocardial ischemia in patients with implanted pacemakers.
 ...
PMID:[Dobutamine stress echocardiography in the diagnosis of myocardial ischemia in patients with implanted pacemakers: report of two cases]. 855 15

Dobutamine stress echocardiography is frequently used for preoperative assessment of cardiac risk before major vascular surgical procedures. Dobutamine increases myocardial contractility, heart rate, and rate of increase of left ventricular pressure and has a variable effect on blood pressure. These effects could potentially increase the likelihood of rupture of a vascular aneurysm. The safety of performing dobutamine stress echocardiography in patients with vascular aneurysms has not been adequately addressed. Of 1,968 consecutive patients who underwent dobutamine stress echocardiography at our institution, 98 patients with abdominal aortic aneurysms > or = 4 cm in diameter were identified. Records were reviewed to determine whether there was any evidence of aneurysm rupture or adverse vascular events as a result of the stress test. There was no case of aneurysm rupture or hemodynamic instability precipitated by dobutamine stress echocardiography. In addition, dobutamine stress echocardiography that was negative for ischemia identified patients at very low risk of perioperative cardiac events. The positive predictive value of ischemia during dobutamine echocardiography was 29%. Dobutamine stress echocardiography may be performed safely in patients with aortic aneurysms. Precipitation of an aneurysmal complication, including rupture, by the test is unlikely. In addition, preoperative dobutamine stress echocardiography can identify patients at very low risk of perioperative cardiac events.
 ...
PMID:Safety of performing dobutamine stress echocardiography in patients with abdominal aortic aneurysm > or = 4 cm in diameter. 860 73


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>